Solumedrol: Clinical Trials

10 trials of Solumedrol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 10 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Completed 10
Phase 31Completed 1

Follow Solumedrol: new trials by email Literature Review of Solumedrol trials Research Report on Solumedrol

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Prospective Evaluation of Peri-Operative Glucocorticoid Use in the Management of Cervicofacial Infections of Odontogenic Origin
Methylprednisolone - Odontogenic Infection of Jaw (Disorder)
Phase 2 / Phase 3CompletedUniversity of Manitoba292022-06-222023-07-21
Tocilizumab in Active Moderate-severe Graves' Orbitopathy
Tocilizumab 20 Mg/mL Intravenous Solution, MethylPREDNISolone Injectable Solution - Graves Ophthalmopathy
Phase 2CompletedFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico562019-12-182026-10-23
Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation
Belatacept, Tacrolimus, ATG - Lung Transplant Rejection, Antibody-mediated Rejection
Phase 2CompletedWashington University School of Medicine272019-12-172022-11-25
Intrathecal Rituximab in Progressive Multiple Sclerosis
Rituximab IT, methylprednisolone IV, Rituximab IV - Multiple Sclerosis, Chronic Progressive, Nervous System Diseases
Phase 2CompletedCentre Hospitalier de PAU102015-11-302019-10-03
Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)
Basiliximab, Methylprednisolone, Prednisone - Amyotrophic Lateral Sclerosis (ALS)
Phase 2CompletedEmory University312013-10-012017-11-06
Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
Autologous peripheral blood stem cells (auto-PBSC) transplantation, Allogeneic peripheral blood stem cells (allo-PBSC) transplantation, Filgrastim - Transplantation, Homologous, Transplantation, Autologous
Phase 2CompletedStanford University92009-05-012017-10-20
Intrapleural Methylprednisolone Injection for Multiple Organ Failure With Acute Respiratory Distress Syndrome
conventional ECMO with intravenous steroid, solumedrol - Acute Respiratory Distress Syndrome (ARDS), Multiple Organ Failure
Phase 2CompletedNational Taiwan University Hospital292005-06-012011-08-26
Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
Total lymphoid irradiation, Rituximab, Anti-thymoglobulin, rabbit (ATG, rabbit ATG) - Leukemia, Mast-Cell, Mantle-cell Lymphoma
Phase 2CompletedStanford University362005-06-012017-11-28
Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia
Rituximab, Cyclophosphamide (CTX), Doxorubicin - Leukemia, Acute Lymphoblastic Leukemia
Phase 2CompletedM.D. Anderson Cancer Center2202002-11-012020-12-03
Allogeneic Transplantation From Related Haploidentical Donors
non-myeloablative hematopoietic cell transplantation, Anti-Thymocyte Globulin, Cyclosporine - Blood Cancer, Leukemia
Phase 2CompletedStanford University162000-08-012019-12-04

Conditions studied

Leukemia (2)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Graft vs Host Disease (1)  ·  Graves Disease (1)  ·  Graves Ophthalmopathy (1)  ·  Hematologic Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Hyperthyroidism (1)  ·  Leukemia, Mast-Cell (1)  ·  Lymphoma (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Multiple Myeloma (1)  ·  Multiple Organ Failure (1)  ·  Multiple Sclerosis, Chronic Progressive (1)  ·  Neoplasms (1)

Sponsors

Stanford University (3)  ·  Centre Hospitalier de PAU (1)  ·  Emory University (1)  ·  Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1)  ·  M.D. Anderson Cancer Center (1)  ·  National Taiwan University Hospital (1)  ·  University of Manitoba (1)  ·  Washington University School of Medicine (1)

Countries

United States (6)  ·  Canada (1)  ·  France (1)  ·  Italy (1)  ·  Taiwan (1)

Top investigators

Christina N Fournier, MD (1)  ·  David Miklos (1)  ·  Jonathan D Glass, MD (1)  ·  Mario MS Salvi, MD (1)  ·  Mickael Bonnan, MD (1)  ·  Pei-Ming Huang, MD, MS (1)  ·  Ramsey R Hachem, MD (1)  ·  Robert Lowsky (1)  ·  Ryan McCoy, DDS (1)  ·  Susan O'Brien, M.D. (1)  ·  Wen-Kai Weng (1)

Results publications

PMID 22563089, PMID 29308669, PMID 37899481

NIH funding

P01CA049605 (1)